![Mifepristone (RU 486) in Cushing's syndrome in: European Journal of Endocrinology Volume 157 Issue 5 (2007) Mifepristone (RU 486) in Cushing's syndrome in: European Journal of Endocrinology Volume 157 Issue 5 (2007)](https://eje.bioscientifica.com/view/journals/eje/157/5/images/large/full-561fig1.jpeg)
Mifepristone (RU 486) in Cushing's syndrome in: European Journal of Endocrinology Volume 157 Issue 5 (2007)
![Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity | Scientific Reports Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-38671-y/MediaObjects/41598_2019_38671_Fig1_HTML.png)
Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity | Scientific Reports
Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda | The National Academies Press
![Is It Time To Revisit Prescribing Restrictions On Abortion Drug Mifepristone? : Shots - Health News : NPR Is It Time To Revisit Prescribing Restrictions On Abortion Drug Mifepristone? : Shots - Health News : NPR](https://media.npr.org/assets/img/2019/07/11/mifepristone_hofler_npr_02_wide-2685e4b3030e20895fca8bbdbc222ae6e16327c7.jpg?s=1400)
Is It Time To Revisit Prescribing Restrictions On Abortion Drug Mifepristone? : Shots - Health News : NPR
![Change of guidance needed for management of missed miscarriage, researchers say - The Pharmaceutical Journal Change of guidance needed for management of missed miscarriage, researchers say - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/01/Mifepristone-AL20-scaled.jpg)
Change of guidance needed for management of missed miscarriage, researchers say - The Pharmaceutical Journal
![Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries - Journal of Obstetrics and Gynaecology Canada Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries - Journal of Obstetrics and Gynaecology Canada](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/5095240e-28f1-4524-b13e-30a3a20433b2/gr1.jpg)
Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries - Journal of Obstetrics and Gynaecology Canada
![FDA Lifts Some Abortion Pill Restrictions, Leaves Others in Place: “Ignores the Science and Smacks of Political Interference” - Ms. Magazine FDA Lifts Some Abortion Pill Restrictions, Leaves Others in Place: “Ignores the Science and Smacks of Political Interference” - Ms. Magazine](https://msmagazine.com/wp-content/uploads/2021/12/Medication-Abortion-Care-Is-Safe-and-Effective%E2%80%94Its-Time-Everyone-Has-Equal-Access-1.jpg)
FDA Lifts Some Abortion Pill Restrictions, Leaves Others in Place: “Ignores the Science and Smacks of Political Interference” - Ms. Magazine
![Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/fef9e9bf-4d3b-46fa-908f-d757194411f7/gr1.gif)